-
Je něco špatně v tomto záznamu ?
Immunoglobulin heavy variable (IGHV) genes and alleles: new entities, new names and implications for research and prognostication in chronic lymphocytic leukaemia
A Xochelli, A Agathangelidis, I Kavakiotis, E Minga, LA Sutton, P Baliakas, I Chouvarda, V Giudicelli, I Vlahavas, N Maglaveras, L Bonello, L Trentin, A Tedeschi, P Panagiotidis, C Geisler, AW Langerak, S Pospisilova, DF Jelinek, D Oscier, N...
Jazyk angličtina Země Spojené státy americké
Grantová podpora
NT13493
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
ProQuest Central
od 2003-01-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 2000-01-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 2003-01-01 do Před 1 rokem
- MeSH
- alely MeSH
- chronická lymfatická leukemie * genetika imunologie patologie MeSH
- hypervariabilní oblasti * genetika MeSH
- lidé MeSH
- mutace MeSH
- prognóza * MeSH
- sekvence aminokyselin genetika MeSH
- sekvenční seřazení MeSH
- Check Tag
- lidé MeSH
Nuext generation sequencing studies in Homo sapiens have identified novel immunoglobulin heavy variable (IGHV) genes and alleles necessitating changes in the international ImMunoGeneTics information system (IMGT) GENE-DB and reference directories of IMGT/V-QUEST. In chronic lymphocytic leukaemia (CLL), the somatic hypermutation (SHM) status of the clonotypic rearranged IGHV gene is strongly associated with patient outcome. Correct determination of this parameter strictly depends on the comparison of the nucleotide sequence of the clonotypic rearranged IGHV gene with that of the closest germline counterpart. Consequently, changes in the reference directories could, in principle, affect the correct interpretation of the IGHV mutational status in CLL. To this end, we analyzed 8066 productive IG heavy chain (IGH) rearrangement sequences from our consortium both before and after the latest update of the IMGT/V-QUEST reference directory. Differences were identified in 405 cases (5 % of the cohort). In 291/405 sequences (71.9 %), changes concerned only the IGHV gene or allele name, whereas a change in the percent germline identity (%GI) was noted in 114/405 (28.1 %) sequences; in 50/114 (43.8 %) sequences, changes in the %GI led to a change in the mutational set. In conclusion, recent changes in the IMGT reference directories affected the interpretation of SHM in a sizeable number of IGH rearrangement sequences from CLL patients. This indicates that both physicians and researchers should consider a re-evaluation of IG sequence data, especially for those IGH rearrangement sequences that, up to date, have a GI close to 98 %, where caution is warranted.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19036291
- 003
- CZ-PrNML
- 005
- 20191009140535.0
- 007
- ta
- 008
- 191009s2015 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00251-014-0812-3 $2 doi
- 035 __
- $a (PubMed)25388851
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Xochelli A $u Xochelli, Aliki. Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece.
- 245 10
- $a Immunoglobulin heavy variable (IGHV) genes and alleles: new entities, new names and implications for research and prognostication in chronic lymphocytic leukaemia / $c A Xochelli, A Agathangelidis, I Kavakiotis, E Minga, LA Sutton, P Baliakas, I Chouvarda, V Giudicelli, I Vlahavas, N Maglaveras, L Bonello, L Trentin, A Tedeschi, P Panagiotidis, C Geisler, AW Langerak, S Pospisilova, DF Jelinek, D Oscier, N Chiorazzi, N Darzentas, F Davi, P Ghia, R Rosenquist, A Hadzidimitriou, C Belessi, MP Lefranc, K Stamatopoulos
- 520 9_
- $a Nuext generation sequencing studies in Homo sapiens have identified novel immunoglobulin heavy variable (IGHV) genes and alleles necessitating changes in the international ImMunoGeneTics information system (IMGT) GENE-DB and reference directories of IMGT/V-QUEST. In chronic lymphocytic leukaemia (CLL), the somatic hypermutation (SHM) status of the clonotypic rearranged IGHV gene is strongly associated with patient outcome. Correct determination of this parameter strictly depends on the comparison of the nucleotide sequence of the clonotypic rearranged IGHV gene with that of the closest germline counterpart. Consequently, changes in the reference directories could, in principle, affect the correct interpretation of the IGHV mutational status in CLL. To this end, we analyzed 8066 productive IG heavy chain (IGH) rearrangement sequences from our consortium both before and after the latest update of the IMGT/V-QUEST reference directory. Differences were identified in 405 cases (5 % of the cohort). In 291/405 sequences (71.9 %), changes concerned only the IGHV gene or allele name, whereas a change in the percent germline identity (%GI) was noted in 114/405 (28.1 %) sequences; in 50/114 (43.8 %) sequences, changes in the %GI led to a change in the mutational set. In conclusion, recent changes in the IMGT reference directories affected the interpretation of SHM in a sizeable number of IGH rearrangement sequences from CLL patients. This indicates that both physicians and researchers should consider a re-evaluation of IG sequence data, especially for those IGH rearrangement sequences that, up to date, have a GI close to 98 %, where caution is warranted.
- 590 __
- $a bohemika - dle Pubmed
- 650 02
- $a alely $7 D000483
- 650 02
- $a sekvence aminokyselin $x genetika $7 D000595
- 650 12
- $a hypervariabilní oblasti $x genetika $7 D022801
- 650 02
- $a lidé $7 D006801
- 650 12
- $a chronická lymfatická leukemie $x genetika $x imunologie $x patologie $7 D015451
- 650 02
- $a mutace $7 D009154
- 650 12
- $a prognóza $7 D011379
- 650 02
- $a sekvenční seřazení $7 D016415
- 700 1_
- $a Agathangelidis A
- 700 1_
- $a Kavakiotis I
- 700 1_
- $a Minga E
- 700 1_
- $a Sutton LA
- 700 1_
- $a Baliakas P
- 700 1_
- $a Chouvarda I
- 700 1_
- $a Giudicelli V
- 700 1_
- $a Vlahavas I
- 700 1_
- $a Maglaveras N
- 700 1_
- $a Bonello L
- 700 1_
- $a Trentin L
- 700 1_
- $a Tedeschi A
- 700 1_
- $a Panagiotidis P
- 700 1_
- $a Geisler C
- 700 1_
- $a Langerak AW
- 700 1_
- $a Pospíšilová, Šárka, $d 1969- $7 xx0101843
- 700 1_
- $a Jelinek DF
- 700 1_
- $a Oscier D
- 700 1_
- $a Chiorazzi N
- 700 1_
- $a Darzentas, Nicos $7 xx0238322
- 700 1_
- $a Davi F
- 700 1_
- $a Ghia P
- 700 1_
- $a Rosenquist R
- 700 1_
- $a Hadzidimitriou A
- 700 1_
- $a Belessi C
- 700 1_
- $a Lefranc MP
- 700 1_
- $a Stamatopoulos K
- 773 0_
- $t Immunogenetics $g Roč. 67, č. 1 (2015), s. 61-66 $p Immunogenetics $x 0093-7711 $w MED00002190
- 773 0_
- $p Immunogenetics $g 67(1):61-6, 2015 Jan
- 910 __
- $a ABA008 $b sig $y 4 $z 0
- 990 __
- $a 20191009140953 $b ABA008
- 991 __
- $a 20191009140953 $b ABA008
- 999 __
- $a ok $b bmc $g 1453154 $s 1074851
- BAS __
- $a 3
- BMC __
- $a 2015 $b 67 $c 1 $d 61-66 $x MED00002190 $i 0093-7711 $m Immunogenetics
- GRA __
- $a NT13493 $p MZ0
- LZP __
- $a NLK 2019/lp